Q&A

Guidelines on Hematuria: Urologic and Nephrologic Evaluation

Author and Disclosure Information

Guidelines from the American Urological Association address your questions about patients with blood in the urine.


 

The American Urological Association (AUA) published guidelines for asymptomatic microhematuria. The document includes 19 guidelines with recommendation levels ranging from A to C (high to low) and some expert opinion recommendations included. The full guidelines can be accessed at http://www.auanet.org/common/pdf/education/clinical-guidance/Asymptomatic-Microhematuria.pdf.

Q: I have a 58-year-old female patient who is taking warfarin for atrial fibrillation and is complaining about blood in her urine. She is postmenopausal, so I think it is just the warfarin. Other than checking her international normalized ratio (INR), what else should I be doing?

In addition to checking an INR, it is important to investigate benign causes for the hematuria. Asymptomatic hematuria requires obtaining a thorough history, which includes common risk factors for urinary tract malignancy, physical exam, and laboratory evaluation. Initially, a noncontaminated urinalysis with culture and sensitivity should be obtained to rule out infection.

If a benign cause cannot be found in any patient undergoing anticoagulation therapy, the AUA (guideline 6) 1 recommends a urologic and nephrologic evaluation. Anticoagulation therapy would include all anticoagulant and antiplatelet agents, such as aspirin, Plavix (clopidogrel), Pletal (cilostazol), Coumadin (warfarin), heparin, or heparin derivatives, such as Lovenox (enoxaparin).

The urologic evaluation may include urology referral, cystoscopy for patients 35 or older, and multiphasic CT urography, performed with and without contrast. A nephrologic evaluation would initially include a urinalysis, calculated eGFR, creatinine, and BUN, and a nephrology referral when indicated. A thorough evaluation is indicated for all patients with hematuria who are on anticoagulant therapy to ensure that a urinary tract malignancy is not present.

AUA guidelines 10 through 13 1 address alternative tests for patients with kidney disease in whom contrast dye is contraindicated.

Kristy Washinger , MSN, CRNP, Nephrology Associates of Central Pennsylvania, Camp Hill, PA

References
1. Davis R, Jones JS, Barocas DA, et al; American Urological Association. Diagnosis, Evaluation, and Follow-up of Asymptomatic Microhematuria (AMH) in Adults: AUA Guideline. Linthicum, MD: American Urological Association Education and Research, Inc; 2012. http://www.auanet.org/common/pdf/education/clinical-guidance/Asymptomatic-Microhematuria.pdf. Accessed January 24, 2013.
2. National Kidney and Urologic Diseases Information Clearinghouse. Hematuria: blood in the urine (2012). http://kidney.niddk.nih.gov/kudiseases/pubs/hematuria. Accessed January 17, 2013.
3. Geavlete B, Jecu M, Multescu R, et al. HAL blue-light cystoscopy in high-risk nonmuscle-invasive bladder cancer: re-TURBT recurrence rates in a prospective, randomized study. Urology. 2010;76(3):664-669.

Suggested Reading
Feldman AS, Hsu C-Y, Kurtz M, Cho KC. Etiology and evaluation of hematuria in adults (2012). www.uptodate.com/contents/etiology-and-evaluation-of-hematuria-in-adults. Accessed January 17, 2013.
Jayne D. Hematuria and proteinuria. In: Greenberg A, ed; National Kidney Foundation. Primer on Kidney Diseases . 5th ed. Saunders; 2009:33-42.

Recommended Reading

Dialysis: How, When, and at What Dose?
Clinician Reviews
Statin Use
Clinician Reviews
Kidney Failure Risk
Clinician Reviews
Loop Diuretics
Clinician Reviews
Management Specifics in Kidney Disease: Dietary Potassium
Clinician Reviews
Management of Hypertensive Urgency and Emergency
Clinician Reviews
Kidney Failure in the 21st Century
Clinician Reviews
Developing Renal Education Classes
Clinician Reviews
Management Specifics in Kidney Disease: Fluid Prep for Cardiac Catheterizations
Clinician Reviews
Management Specifics in Kidney Disease: Rise in SCr
Clinician Reviews

Related Articles